Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-

From the Division of Cardiology (D.R.W., A.C., C.M., B.L., A.M.F.) and the Division of Neuropathology (V.J.S.), University of Pittsburgh (Pa) Medical Center.

Correspondence to Arthur M. Feldman, MD, PhD, University of Pittsburgh Medical Center, Division of Cardiology, S572 Scaife Hall, 200 Lothrop St, Pittsburgh, PA 15213. E-mail feldma{at}card2.cath.upmc.edu

Abstract—Tumor necrosis factor- (TNF-) is elevated in the failing heart. Very little is known about regulation of TNF- in cardiomyocytes. TNF- expression by macrophages is diminished by adenosine. Therefore, we hypothesized that a similar mechanism might occur in the heart. Neonatal rat myocytes were stimulated with lipopolysaccharide (LPS), and TNF- was measured by ELISA. In the absence of LPS, myocytes did not release TNF- in the medium. After exposure to LPS, TNF- increased to 70.1±3.5 pg/mL at 6 hours. Immunofluorescent staining confirmed that TNF- was expressed in myocytes. Adenosine decreased TNF- in a dose-dependent manner (1 to 100 µmol/L, 37% to 65% decrease, P<.01). Adenosine also decreased TNF- in cell homogenates by 78% (P<.0001). The effect of adenosine could be replicated by the A₂ agonist PD-125944 (DPMA), by cAMP agonists 8-bromo-cAMP, forskolin, and Ro 20–1724, but not by A₁ and A₃ agonists. Conversely, the effect of adenosine could be suppressed by the adenylate cyclase inhibitor MDL-12,330. Adenosine also inhibited TNF- in adult rat ventricular myocytes (-60%, P<.005) and rat papillary muscles (-55%, P<.05). In neonatal myocytes, adenosine normalized LPS-induced calcium changes and improved LPS-induced negative inotropic (P<.01) and negative lusitropic (P<.01) effects. Our results demonstrate that adenosine can significantly diminish TNF- levels in the heart. The effect appears to be mediated by the A₂ receptor and transduced through a G protein–adenylyl cyclase pathway. These results may explain some cardioprotective effects of adenosine and provide a novel pharmacological intervention in congestive heart failure.

Key Words: adenosine • tumor necrosis factor- • cytokine • cardiomyocyte • myocardium

This article has been cited by other articles:

				Y. Hiraumi, E. Iwai-Kanai, S. Baba, Y. Yui, Y. Kamitsuji, Y. Mizushima, H. Matsubara, M. Watanabe, K.-i. Watanabe, S. Toyokuni, et al. Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H823 - H832. [Abstract] [Full Text] [PDF]

				E. Velot, B. Haas, F. Leonard, I. Ernens, M. Rolland-Turner, C. Schwartz, D. Longrois, Y. Devaux, and D. R. Wagner Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages Cardiovasc Res, November 1, 2008; 80(2): 246 - 254. [Abstract] [Full Text] [PDF]

				X. Xu, J. Fassett, X. Hu, G. Zhu, Z. Lu, Y. Li, J. Schnermann, R. J. Bache, and Y. Chen Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction Hypertension, June 1, 2008; 51(6): 1557 - 1564. [Abstract] [Full Text] [PDF]

				I. Ernens, D. Rouy, E. Velot, Y. Devaux, and D. R. Wagner Adenosine Inhibits Matrix Metalloproteinase-9 Secretion By Neutrophils: Implication of A2a Receptor and cAMP/PKA/Ca2+ Pathway Circ. Res., September 15, 2006; 99(6): 590 - 597. [Abstract] [Full Text] [PDF]

				O. Levy, M. Coughlin, B. N. Cronstein, R. M. Roy, A. Desai, and M. R. Wessels The Adenosine System Selectively Inhibits TLR-Mediated TNF-{alpha} Production in the Human Newborn J. Immunol., August 1, 2006; 177(3): 1956 - 1966. [Abstract] [Full Text] [PDF]

				T. L. Butler, C. G. Au, B. Yang, J. R. Egan, Y. M. Tan, E. C. Hardeman, K. N. North, A. S. Verkman, and D. S. Winlaw Cardiac aquaporin expression in humans, rats, and mice Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H705 - H713. [Abstract] [Full Text] [PDF]

				A. S. Weyrich, M. M. Denis, J. R. Kuhlmann-Eyre, E. D. Spencer, D. A. Dixon, G. K. Marathe, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet-Monocyte Aggregates Circulation, February 8, 2005; 111(5): 633 - 642. [Abstract] [Full Text] [PDF]

				A. M. Feldman The emerging role of pharmacogenomics in the treatment of patients with heart failure Ann. Thorac. Surg., December 1, 2003; 76(6): S2246 - 2253. [Full Text] [PDF]

				J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF]

				T. Peng, X. Lu, M. Lei, and Q. Feng Endothelial Nitric-oxide Synthase Enhances Lipopolysaccharide-stimulated Tumor Necrosis Factor-alpha Expression via cAMP-mediated p38 MAPK Pathway in Cardiomyocytes J. Biol. Chem., February 28, 2003; 278(10): 8099 - 8105. [Abstract] [Full Text] [PDF]

				H. L. Li, J. Suzuki, E. Bayna, F.-M. Zhang, E. Dalle Molle, A. Clark, R. L. Engler, and W. Y. W. Lew Lipopolysaccharide induces apoptosis in adult rat ventricular myocytes via cardiac AT1 receptors Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H461 - H467. [Abstract] [Full Text] [PDF]

				M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF]

				G. Wright, I. S. Singh, J. D. Hasday, I. K. Farrance, G. Hall, A. S. Cross, and T. B. Rogers Endotoxin stress-response in cardiomyocytes: NF-kappa B activation and tumor necrosis factor-alpha expression Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H872 - H879. [Abstract] [Full Text] [PDF]

				L. LIAUDET, J. G. MABLEY, F. G. SORIANO, P. PACHER, A. MARTON, G. HASKO, and C. SZABO Inosine Reduces Systemic Inflammation and Improves Survival in Septic Shock Induced by Cecal Ligation and Puncture Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1213 - 1220. [Abstract] [Full Text] [PDF]

				T. Kadokami, C. F. McTiernan, T. Kubota, C. S. Frye, G. S. Bounoutas, P. D. Robbins, S. C. Watkins, and A. M. Feldman Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2281 - H2291. [Abstract] [Full Text] [PDF]

				B. Tantini, F. Flamigni, C. Pignatti, C. Stefanelli, M. Fattori, A. Facchini, E. Giordano, C. Clo, and C. M. Caldarera Polyamines, NO and cGMP mediate stimulation of DNA synthesis by tumor necrosis factor and lipopolysaccharide in chick embryo cardiomyocytes Cardiovasc Res, February 1, 2001; 49(2): 408 - 416. [Abstract] [Full Text] [PDF]

				N. M. Filipov, F. N. Thompson, J. A. Stuedemann, T. H. Elsasser, S. Kahl, L. H. Stanker, C. R. Young, D. L. Dawe, and C. K. Smith Anti-Inflammatory Effects of Ergotamine in Steers Exp Biol Med, November 1, 2000; 225(2): 136 - 142. [Abstract] [Full Text] [PDF]

				H. Takano, T. Nagai, M. Asakawa, T. Toyozaki, T. Oka, I. Komuro, T. Saito, and Y. Masuda Peroxisome Proliferator-Activated Receptor Activators Inhibit Lipopolysaccharide-Induced Tumor Necrosis Factor-{alpha} Expression in Neonatal Rat Cardiac Myocytes Circ. Res., September 29, 2000; 87(7): 596 - 602. [Abstract] [Full Text] [PDF]

				A. M. Feldman, A. Combes, D. Wagner, T. Kadakomi, T. Kubota, Y. You Li, and C. McTiernan The role of tumor necrosis factor in the pathophysiology of heart failure J. Am. Coll. Cardiol., March 1, 2000; 35(3): 537 - 544. [Abstract] [Full Text] [PDF]

				W. J. Paulus How are cytokines activated in heart failure? Eur J Heart Fail, December 17, 1999; 1(4): 309 - 312. [Full Text] [PDF]

				M Tendera and H Wysocki TNF-{alpha} in patients with chronic failure is not only a proinflammatory cytokine Eur. Heart J., October 2, 1999; 20(20): 1445 - 1446. [PDF]

				G. S. Francis TNF-{alpha} and Heart Failure : The Difference Between Proof of Principle and Hypothesis Testing Circulation, June 29, 1999; 99(25): 3213 - 3214. [Full Text] [PDF]

				T. Yokoyama, K. Sekiguchi, T. Tanaka, K. Tomaru, M. Arai, T. Suzuki, and R. Nagai Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1968 - H1976. [Abstract] [Full Text] [PDF]

				D. R. Wagner, T. Kubota, V. J. Sanders, C. F. McTiernan, and A. M. Feldman Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2141 - H2147. [Abstract] [Full Text] [PDF]

				S. Sasayama, A. Matsumori, and Y. Kihara New insights into the pathophysiological role for cytokines in heart failure Cardiovasc Res, June 1, 1999; 42(3): 557 - 564. [Full Text] [PDF]

				A. M. Feldman, D. R. Wagner, and D. M. McNamara AMPD1 Gene Mutation in Congestive Heart Failure : New Insights Into the Pathobiology of Disease Progression Circulation, March 23, 1999; 99(11): 1397 - 1399. [Full Text] [PDF]

				D. R. Wagner, C. McTiernan, V. J. Sanders, and A. M. Feldman Adenosine Inhibits Lipopolysaccharide-Induced Secretion of Tumor Necrosis Factor-{alpha} in the Failing Human Heart Circulation, February 17, 1998; 97(6): 521 - 524. [Abstract] [Full Text] [PDF]

				M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF]